MedTrace Logo

Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.021).

NCT01703520 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 575216

Last updated 2024-05-10

No results posted yet for this study

Summary

The objective of this study is to investigate the potential association between finasteride (MK-0906) exposure and the development of breast cancer in men residing in Denmark, Sweden, Finland, and Norway from data in national registries. The primary hypothesis of this study is that the previously reported increased incidence of male breast cancer among finasteride users is explained by confounding factors.

Conditions

  • Male Breast Cancer

Sponsors & Collaborators

  • Institute for Applied Economics and Health Research Aps

    collaborator UNKNOWN

  • Organon and Co

    lead INDUSTRY

Principal Investigators

  • Medical Director · Merck Sharp & Dohme LLC

Eligibility

Min Age
35 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-01
Primary Completion
2017-11-30
Completion
2017-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01703520 on ClinicalTrials.gov